Trial Profile
Etanercept in the treatment of patients with non-radiographic axial spondyloarthritis.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 28 Aug 2015
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Ankylosing spondylitis; Non-radiographic axial spondyloarthritis
- Focus Therapeutic Use
- 28 Aug 2015 New trial record